File Download
  Links for fulltext
     (May Require Subscription)
  • Find via Find It@HKUL
Supplementary

Conference Paper: A phase IIb study of the efficacy and safety of LB80380 vs entecavir in treatment-naive patients with chronic hepatitis B

TitleA phase IIb study of the efficacy and safety of LB80380 vs entecavir in treatment-naive patients with chronic hepatitis B
Authors
Lai, CLAhn, SHLee, KSUm, SHCho, MYoon, SKLee, JWPark, NWKwon, YOSohn, JHLee, JYPark, HEKim, JAHan, KHYuen, MF
Issue Date2011
PublisherElsevier BV.
Citation
The International Liver Congress - The 46th Annual Meeting of the European Association for the Study of the Liver (EASL 2011), Berlin, Germany, 30 March-3 April 2011. In Hepatology, 2011, v. 54 suppl. 1, p. S535, abstract no. 1353 How to Cite?
DescriptionParallel Session: Late-breaker Oral Presentations
Persistent Identifierhttp://hdl.handle.net/10722/140459
ISSN
0169-5185

 

DC FieldValueLanguage
dc.contributor.authorLai, CLen_US
dc.contributor.authorAhn, SHen_US
dc.contributor.authorLee, KSen_US
dc.contributor.authorUm, SHen_US
dc.contributor.authorCho, Men_US
dc.contributor.authorYoon, SKen_US
dc.contributor.authorLee, JWen_US
dc.contributor.authorPark, NWen_US
dc.contributor.authorKwon, YOen_US
dc.contributor.authorSohn, JHen_US
dc.contributor.authorLee, JYen_US
dc.contributor.authorPark, HEen_US
dc.contributor.authorKim, JAen_US
dc.contributor.authorHan, KHen_US
dc.contributor.authorYuen, MFen_US
dc.date.accessioned2011-09-23T06:12:03Z-
dc.date.available2011-09-23T06:12:03Z-
dc.date.issued2011en_US
dc.identifier.citationThe International Liver Congress - The 46th Annual Meeting of the European Association for the Study of the Liver (EASL 2011), Berlin, Germany, 30 March-3 April 2011. In Hepatology, 2011, v. 54 suppl. 1, p. S535, abstract no. 1353en_US
dc.identifier.issn0169-5185-
dc.identifier.urihttp://hdl.handle.net/10722/140459-
dc.descriptionParallel Session: Late-breaker Oral Presentations-
dc.languageengen_US
dc.publisherElsevier BV.-
dc.relation.ispartofHepatologyen_US
dc.titleA phase IIb study of the efficacy and safety of LB80380 vs entecavir in treatment-naive patients with chronic hepatitis Ben_US
dc.typeConference_Paperen_US
dc.identifier.openurlConference_Paper-
dc.identifier.emailLai, CL: hrmelcl@hku.hken_US
dc.identifier.emailYuen, MF: mfyuen@hku.hken_US
dc.identifier.authorityLai, CL=rp00314en_US
dc.identifier.authorityYuen, MF=rp00479en_US
dc.description.naturelink_to_OA_fulltext-
dc.identifier.hkuros196145en_US
dc.identifier.hkuros196628-
dc.identifier.volume54en_US
dc.identifier.issuesuppl. 1-
dc.identifier.spageS535en_US
dc.identifier.epageS535en_US
dc.description.otherThe International Liver Congress - The 46th Annual Meeting of the European Association for the Study of the Liver (EASL 2011), Berlin, Germany, 30 March-3 April 2011. In Hepatology, 2011, v. 54 suppl. 1, p. S535, abstract no. 1353-
dc.identifier.issnl0169-5185-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats